Principal Investigators

    KU Leuven, Faculteit Geneeskunde, Dept Neurowetenschappen, Onderzoeksgroep Experimentele Neurologie


    KU Leuven

    Contact information of lead PI



    Title of project or programme

    Biomarker based adaptive development in Alzheimer disease (BioAdaptAD)

    Source of funding information

    Flanders Innovation & Entrepreneurship

    Total sum awarded (Euro)

    € 979,720

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Alzheimer's disease & other dementias


    Research Abstract

    The general objectives of this project are to develop a BACE inhibitor for disease modification in Alzheimer’s disease and to explore the development in an earlier prodromal Alzheimer’s disease population. From a drug development perspective, this will involve multiple adaptation steps and the intensive use of biomarkers.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Belgium
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF